In March 2012, the World Health Organization (WHO) held a Technical Consultation on the Prevention and Treatment of Postpartum Haemorrhage to review current evidence and to update previously published PPH guidelines.1 The new guidelines combine previous documents to address both prevention and treatment—recognizing the importance of integrated care.
Full Answer
Are there who guidelines for the prevention and treatment of postpartum hemorrhage?
WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage Review Geneva: World Health Organization; 2012. WHO Guidelines Approved by the Guidelines Review Committee. PMID: 23586122 Bookshelf ID: NBK131942 Excerpt
When did who hold a technical consultation on postpartum hemorrhage?
In March 2012, WHO held a Technical Consultation on the Prevention and Treatment of Postpartum Haemorrhage to review curren … Improving health care for women during childbirth in order to prevent and treat postpartum hemorrhage (PPH) is an essential step toward achieving Millennium Development Goal 5.
What is postpartum haemorrhage (PPH)?
Postpartum haemorrhage (PPH) is a major cause of mortality, morbidity and long term disability related to pregnancy and childbirth. Effective interventions to prevent and treat PPH exist and can largely reduce the burden of this life-threatening condition.
When is misoprostol (600 μg Po) given for PPH prevention?
misoprostol (600 μg) should be given. When skilled birth attendants are not present and oxytocin is unavailable, community health care and lay health workers should administer misoprostol (600 μg PO) for PPH prevention. PPH PREVENTION: POLICY AND PROGRAMME ACTIONS TO INCORPORATE NEW GUIDELINES
Who PPH prevention guidelines?
The use of an effective uterotonic for the prevention of PPH during the third stage of labour is recommended for all births. 2. In settings where multiple uterotonic options are available, oxytocin (10 IU, IM/IV) is the recommended uterotonic agent for the prevention of PPH for all births.
What is the prevention of postpartum haemorrhage?
The most effective strategy to prevent postpartum hemorrhage is active management of the third stage of labor (AMTSL). AMTSL also reduces the risk of a postpartum maternal hemoglobin level lower than 9 g per dL (90 g per L) and the need for manual removal of the placenta.
What medications are used for prevention and treatment of postpartum hemorrhage?
SORT: KEY RECOMMENDATIONS FOR PRACTICEClinical recommendationEvidence ratingReferencesOxytocin (Pitocin) is the first choice for prevention of postpartum hemorrhage because it is as effective or more effective than ergot alkaloids or prostaglandins and has fewer side effects.A2,25,265 more rows•Mar 15, 2007
What interventions should be implemented for postpartum hemorrhage?
External uterine massage and bimanual compression are generally used as first-line treatments. These compression techniques encourage uterine contractions that counteract atony and assist with expulsion of retained placenta or clots. Aortic compression is another compression technique that has been used for severe PPH.
WHO recommendations Uterotonics for prevention of postpartum haemorrhage?
The World Health Organization (WHO) recommends provision of prophylactic uterotonics for every woman during the third stage of labour [5]. Five drugs are available for PPH prevention: oxytocin, carbetocin, ergometrine, misoprostol, and prostaglandin.
How do you prevent postpartum complications?
Prevention tips Prioritize your postpartum health. Start thinking about your postpartum care plan before you give birth. After childbirth, talk to your health care provider about your risk of a pregnancy-related complication and any special follow-up care you might need. Know the signs and symptoms of a problem.
What are two drugs used to treat postpartum hemorrhage?
The medications most commonly used in PPH management are uterotonic agents. These medications include oxytocin (Pitocin®), misoprostol (Cytotec®), methylergonovine maleate (Methergine®,), carboprost tromethamine (Hemabate®), and dinoprostone (Prostin E2®). All of these medications are available in the United States.
What is the first line management of postpartum hemorrhage?
Oxytocin is an effective first-line treatment for postpartum hemorrhage31; 10 international units (IU) should be injected intramuscularly, or 20 IU in 1 L of saline may be infused at a rate of 250 mL per hour. As much as 500 mL can be infused over 10 minutes without complications.
How does oxytocin prevent postpartum hemorrhage?
Oxytocin is one such drug. Oxytocin prevents excessive postpartum bleeding by helping the uterus to contract. It is given to the mother by injection into a vein or into muscle during or immediately after the birth of her baby.
What is PPH in medical terms?
Postpartum haemorrhage (PPH) is a major cause of mortality, morbidity and long term disability related to pregnancy and childbirth. Effective interventions to prevent and treat PPH exist and can largely reduce the burden of this life-threatening condition.
Who is the target audience for the Health Policy Document?
Health professionals responsible for developing national and local health policies constitute the main target audience of this document. Obstetricians, midwives, general medical practitioners, health care managers and public health policy-makers, particularly in under-resourced settings are also targeted.
Is postpartum hemorrhage a maternal cause of death?
Despite the progress made in reducing morbidity and mortality due to postpartum hemorrhage (PPH), PPH is still the leading cause of maternal mortality in low-income countries and the primary cause of nearly one-quarter of all maternal deaths globally [1]. Improving health care for women during childbirth in order to prevent and treat PPH is an essential step toward achieving Millennium Development Goal 5.
Is oxytocin used for PPH?
The use of uterotonics—with oxytocin alone as the first choice—has a central role in the treatment of PPH. Intravenous oxytocin is the first-line uterotonic; this recommendation also covers women who have already received this drug for PPH prophylaxis. However, the guidelines acknowledge the fact that IV oxytocin might not be available in all settings owing to shortage of drugs and/or healthcare providers, and they encourage decision makers in these settings to aim to make oxytocin available.
